These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31934719)
1. Effects of emodin on inflammatory bowel disease-related osteoporosis. Luo JS; Zhao X; Yang Y Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31934719 [TBL] [Abstract][Full Text] [Related]
2. Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. Chen X; Ren S; Zhu G; Wang Z; Wen X Environ Toxicol Pharmacol; 2017 Sep; 54():162-168. PubMed ID: 28738286 [TBL] [Abstract][Full Text] [Related]
3. The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model. Ge X; Chen Z; Xu Z; Lv F; Zhang K; Yang Y Exp Biol Med (Maywood); 2018 May; 243(8):715-724. PubMed ID: 29763384 [TBL] [Abstract][Full Text] [Related]
4. Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation. Wang XF; Wang YJ; Li TY; Guo JX; Lv F; Li CL; Ge XT Biomed Pharmacother; 2019 Jul; 115():108916. PubMed ID: 31054506 [TBL] [Abstract][Full Text] [Related]
5. Naringin protects against bone loss in steroid-treated inflammatory bowel disease in a rat model. Li C; Zhang J; Lv F; Ge X; Li G Arch Biochem Biophys; 2018 Jul; 650():22-29. PubMed ID: 29753722 [TBL] [Abstract][Full Text] [Related]
6. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation. Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436 [TBL] [Abstract][Full Text] [Related]
7. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis. Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503 [TBL] [Abstract][Full Text] [Related]
8. Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway. Chen T; Ai G; Liang G; Zeng L; Zhao D; Liu J; Dou Y Biomed Pharmacother; 2024 May; 174():116523. PubMed ID: 38574627 [TBL] [Abstract][Full Text] [Related]
9. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats. Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180 [TBL] [Abstract][Full Text] [Related]
10. Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis. Qi J; Hu KS; Yang HL Int J Clin Exp Pathol; 2015; 8(10):11995-2004. PubMed ID: 26722385 [TBL] [Abstract][Full Text] [Related]
11. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. Narayanan SA; Metzger CE; Bloomfield SA; Zawieja DC FASEB J; 2018 Sep; 32(9):4848-4861. PubMed ID: 29596023 [TBL] [Abstract][Full Text] [Related]
12. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Oh KO; Kim SW; Kim JY; Ko SY; Kim HM; Baek JH; Ryoo HM; Kim JK Clin Chim Acta; 2003 Aug; 334(1-2):185-95. PubMed ID: 12867291 [TBL] [Abstract][Full Text] [Related]
13. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Metzger CE; Narayanan SA; Elizondo JP; Carter AM; Zawieja DC; Hogan HA; Bloomfield SA Sci Rep; 2019 Oct; 9(1):15144. PubMed ID: 31641205 [TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644 [TBL] [Abstract][Full Text] [Related]
15. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis. Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889 [TBL] [Abstract][Full Text] [Related]
16. Protocatechualdehyde inhibits iron overload-induced bone loss by inhibiting inflammation and oxidative stress in senile rats. Tao ZS; Hu XF; Wu XJ; Wang ZY; Shen CL Int Immunopharmacol; 2024 Nov; 141():113016. PubMed ID: 39182269 [TBL] [Abstract][Full Text] [Related]
17. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation. Han SY; Lee KH; Kim YK Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250 [TBL] [Abstract][Full Text] [Related]
18. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells. Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412 [TBL] [Abstract][Full Text] [Related]
19. [Changes in tight junction protein expression and permeability of colon mucosa in rats with dextran sulfate sodium-induced inflammatory bowel disease]. Rao YX; Chen J; Chen LL; Gu WZ; Shu XL Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):976-81. PubMed ID: 23234790 [TBL] [Abstract][Full Text] [Related]
20. Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model. Wang H; Feng T; Guo D; Zhang M; Chen L; Zhou Y Molecules; 2018 Sep; 23(9):. PubMed ID: 30217005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]